Brawn Biotech Ltd. - Research Center
530207 BRAWN Group (X) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
Secured loans
Unsecured loans
Total
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
14.16 |
13.40 |
13.73 |
20.11 |
22.33 |
Less : current liabilities & provisions
8.22 |
6.56 |
5.08 |
11.03 |
13.86 |
Total net current assets
Miscellaneous expenses not written
Total
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
30.00 |
30.00 |
30.00 |
30.00 |
30.00 |